Physician profile
Danielle Daab
NPI 1518339225
$2,694.34
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,085 · 2022: $638 · 2023: $637 · 2024: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $971.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $600.74 | 2021-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $441.42 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Biohaven Pharmaceuticals, INC. | $419.20 | 2021 | |
| Abbvie INC. | $223.36 | 2021-2024 | |
| Lilly USA, LLC | $214.15 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $209.55 | 2021-2024 | |
| Amgen INC. | $142.04 | 2022-2023 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $75.07 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $70.82 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $66.47 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.16 | 2021 | |
| Idorsia Pharmaceuticals US INC | $42.25 | 2022-2023 | Quviviq |
| Exact Sciences Corporation | $32.93 | 2023 | Cologuard Collection Kit |
| Eisai INC. | $28.26 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.50 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18.18 | 2024 | |
| Merck Sharp & Dohme LLC | $16.31 | 2024 | Capvaxive, Gardasil, Gardasil 9 |
| Nevro Corp. | $14.57 | 2022 | |
| Currax Pharmaceuticals LLC | $14.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Daab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.